Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−883.4505 USD
−11.90 M USD
0.00 USD
3.96 M
About Allarity Therapeutics, Inc.
Sector
CEO
Thomas H. Jensen
Headquarters
Boston
Website
Founded
2021
FIGI
BBG012NXCZP8
Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company operates in two geographic areas: Denmark and the United States. The company was founded on April 4, 2021 and is headquartered in Boston, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALLR is 0.9901 USD — it has decreased by −3.87% in the past 24 hours. Watch Allarity Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Allarity Therapeutics, Inc. stocks are traded under the ticker ALLR.
ALLR stock has fallen by −3.87% compared to the previous week, the month change is a −18.17% fall, over the last year Allarity Therapeutics, Inc. has showed a −99.71% decrease.
ALLR reached its all-time high on Dec 21, 2021 with the price of 15,288,000.0000 USD, and its all-time low was 1.0000 USD and was reached on Dec 10, 2024. View more price dynamics on ALLR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALLR stock is 13.19% volatile and has beta coefficient of 1.94. Track Allarity Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Allarity Therapeutics, Inc. there?
Today Allarity Therapeutics, Inc. has the market capitalization of 4.39 M, it has increased by 4.76% over the last week.
Yes, you can track Allarity Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Allarity Therapeutics, Inc. is going to release the next earnings report on May 19, 2025. Keep track of upcoming events with our Earnings Calendar.
ALLR earnings for the last quarter are −7.71 USD per share, whereas the estimation was −8.40 USD resulting in a 8.21% surprise. The estimated earnings for the next quarter are −8.10 USD per share. See more details about Allarity Therapeutics, Inc. earnings.
ALLR net income for the last quarter is −11.59 M USD, while the quarter before that showed −1.63 M USD of net income which accounts for −611.48% change. Track more Allarity Therapeutics, Inc. financial stats to get the full picture.
No, ALLR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 6.00 employees. See our rating of the largest employees — is Allarity Therapeutics, Inc. on this list?
Like other stocks, ALLR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Allarity Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Allarity Therapeutics, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Allarity Therapeutics, Inc. stock shows the sell signal. See more of Allarity Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.